Avalo Therapeutics, Inc. (AVTX)
NCM · Common · CUSIP 15671L109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AVTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
15671L109
Market Cap
Small Cap
Previous Symbol
CERC (changed 8/26/2021)
Previous Name
Cerecor, Inc.
Business: Avalo Therapeutics, Inc. is a clinical stage biotechnology company focused on the treatment of immune dysregulation.

Company Contact

CEO
Garry A. Neil
CFO
Chris Sullivan
Headquarters
1500 Liberty Ridge Drive, Suite 321, Wayne, PA 19087
Phone
410-522-8707
Investor Relations
Christopher Sullivan · 410-803-6793 · ir@avalotx.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »